The University of Chicago Medical Center,

Chicago, Illinois 90603

21 studies enrolling now · 135 studies all time

What they study most

ATTR-CM, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Advanced Adult Hepatocellular Carcinoma, Advanced Cancer, Advanced Gastrointestinal (GI) Malignancies, Advanced Hepatocellular Carcinoma, Advanced Non-squamous Non-Small Cell Lung Cancer

Studies at this site

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
ELEVATE-HFpEF Clinical Study — Recruiting now
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — Recruiting now
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — Recruiting now
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis — Recruiting now
ATEMPT 2.0: Adjuvant T-DM1 vs TH — Recruiting now
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer — Recruiting now
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy — Recruiting now
FITting Non-invasive Tests in Lynch Syndrome Surveillance — Recruiting now
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus — Recruiting now
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer — Recruiting now
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Recruiting now
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies — Recruiting now
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation — Recruiting now
Investigating Periprosthetic Fracture Cultures in Arthroplasty — Recruiting now
Investigating Patient Satisfaction With Smart Knee Implants — Recruiting now
Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain — Recruiting now
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial — Recruiting now
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY — Recruiting now
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). — Recruiting now
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer — Running, not enrolling
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis — Completed
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors — Available (expanded access)
Vasopressor SAT Study — Running, not enrolling
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) — Running, not enrolling
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer — Completed
Extracellular RNA Markers of Liver Disease and Cancer — Stopped early
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
A Prospective Observational Study of TPIAT — Running, not enrolling
VItamin C in Thermal injuRY: The VICToRY Trial — Paused
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis — Completed
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease — Running, not enrolling
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
Diaphragm Ultrasound Measurements With Variations in Modes of Ventilation — Completed
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) — Running, not enrolling
Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) — Completed
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial — Completed
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors — Stopped early
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients — Running, not enrolling
Biomarkers of CASH — Running, not enrolling
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
Parental Decision-Making for Children With Relapsed Neuroblastoma — Running, not enrolling
Comparing the Outcomes Between Rotator Cuff Repair With and Without Suprascapular Nerve Decompression — Completed
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors — Completed
Study of Avelumab-M3814 Combinations — Completed
M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) — Completed